<DOC>
	<DOC>NCT01801982</DOC>
	<brief_summary>This single center study will monitor the developmental progress of PPHN patients who received iv sildenafil in study A1481276. Two visits will be conducted, at 12 and 24 months following the end of study drug infusion.</brief_summary>
	<brief_title>A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN)</brief_title>
	<detailed_description>This study will monitor developmental progress of PPHN patients for 2 years following study treatment, using Bayley III and Hammersmith tools. Data will be explored with descriptive statistics.</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension, Pulmonary</mesh_term>
	<mesh_term>Persistent Fetal Circulation Syndrome</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Any subject who received sildenafil treatment in study A1481276. Signed and dated informed consent document by legal guardian. Any subject who did not receive sildenafil treatment during study A1481276.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>PPHN; development progress after PPHN; developmental progress after sildenafil.</keyword>
</DOC>